SCHEMBL19085541

SCHEMBL19085541

CCCCCC(NC(C)=O)C(=O)OC

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.53
SIRT1 Q96EB6 2/20 0.51
SIRT6 Q8N6T7 1/20 0.51
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
PLA2G2A P14555 1/20 0.47
BIRC2 Q13490 4/20 0.46
PLA2G2C Q5R387 1/20 0.45
TAS1R3 Q7RTX0 4/20 0.45
TAS1R1 Q7RTX1 4/20 0.45
TLR2 O60603 2/20 0.44
HDAC2 Q92769 1/20 0.44
ABCB1 P08183 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8232200 1.00 ZDHHC7 (0.53) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL27883776 0.94 CA1 (0.53) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL11042902 0.94 CA1 (0.53) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL11128090 0.94 CA1 (0.53) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL8234349 0.92 TRPV1 (0.43) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL17378386 0.88 GNPAT (0.42) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL12038919 0.87 ZDHHC7 (0.49) ZDHHC7SIRT1SIRT6PLA2G2ABIRC2
SCHEMBL3241409 0.86 TAS1R3 (0.46) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL711890 0.86 TAS1R3 (0.46) ZDHHC7SIRT1SIRT6CA1CA2
SCHEMBL14944700 0.86 CA1 (0.41) ZDHHC7SIRT1SIRT6CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289951-A2 CIRCULAR RNA COMPOSITIONS AND METHODS Orna Therapeutics, Inc. (US) 2023-12-13 EP disclosed
WO-2018081480-A1 LIPID NANOPARTICLE FORMULATIONS Acuitas Therapeutics, Inc. (CA) 2018-05-03 WO disclosed
WO-2017117528-A1 LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS Acuitas Therapeutics, Inc. (CA) 2017-07-06 WO disclosed